Giving Patients The ‘Right To Try’ Experimental Drugs Is A Political Maneuver, Not A Lifesaver


Published:

After a year in which President Donald Trump devoted much of his health policy attention to the repeal and replace of the Affordable Care Act, Trump used part of his recent State of the Union address to press Congress to focus attention in 2018 on a new health priority – the passage of “right to try” legislation.

Right to try legislation gives terminally ill patients the right to use experimental medications that have not yet been approved by the Food and Drug Administration. In 2017, the US Senate unanimously passed HR 878, legislation that would do just that. The president’s address has pressured the US House to follow suit, where a bill is being voted on this March 13.

President Trump’s push for the passage of right to try nationally builds on the efforts of the Libertarian-leaning Goldwater Institute, which has used the broad popularity of the policy to help achieve passage of similar legislation in 38 states, even though it diverges with current federal regulations.

Despite these state gains and the policy’s growing popularity among states, ethical questions remain about the tangible impact of a federal right to try law on Americans with terminal illnesses. Most notably, a growing body of evidence from policy analysts argues that the legislation would unfortunately accomplish very little change for most patients, and it could actually make it harder to get new drugs approved in the future.

How The Drug Approval Process Works

Pharmaceuticals in the United States are regulated by the FDA. When a drug company develops a new compound intended for patient use, the medication goes through three phases of clinical trials that often take years to complete.

The first phase of trials requires a company to prove the drug is relatively safe for humans – that the drug itself will not poison the patient. These phase 1 trials are often conducted on as few as 30 patients.

In later phases, the clinical trials test whether the drug is effective at treating the condition for which it is intended without problematic side effects. It is at this stage that the vast majority of drugs fail to pass approval, because many drugs turn out to be ineffective or to cause severe side effects.

The right to try legislation the Trump administration is currently pushing would authorize doctors to administer drugs that have cleared the first phase, but which have not yet completed these later human clinical trials. By doing so, the legislation gives terminally ill patients the right to use potentially lifesaving medications without rigorous testing from the FDA and without years of waiting for the drugs to become commercially available.

For people suffering from terminal conditions such as amyotrophic lateral sclerosis, or ALS, for which there are promising treatments in the midst of the approval process, the legislation brings hope.

That said, we believe the promises made by right to try advocates are far greater than the actual impact it will have on patients.

‘Right To Try’ Grants No Real Rights

Despite good intentions – and the legislation’s name – right to try legislation grants no rights. It would merely grant permission for a patient to try to get experimental medication from a pharmaceutical company.

Patients would be allowed to try experimental drugs, but nothing in the legislation would make it mandatory for pharmaceutical companies to provide these medications.

The reasons for a company to withhold a drug are many. Giving access to preapproval drugs can be costly, particularly given the limited supply, and almost no medical insurance will cover experimental treatments. Access to the drugs will likely only be feasible for wealthy Americans who can afford to pay for the treatment, as well as the consequences of any negative side effects out of pocket.

Many drug companies also worry that making the drug available without approval opens them up to lawsuits if the drugs prove ineffective or have unforeseen side effects. The current federal right to try proposal does provide some protections for companies in this regard, but until those protections have been tested in court, it is likely companies will remain cautious.

Providing the drug to patients outside of clinical trials can also be disruptive to the approval process because it can lead to data on negative clinical outcomes outside the highly controlled trial setting. While new legislation prevents this data from being used unless it is deemed “critical to determining safety,” bad outcomes might give the FDA pause and delay the approval of drugs that might otherwise be available sooner.

The ‘Right To Try’ Legislation Changes Very Little

Beyond these issues, federal right to try legislation will have minimal impact on the availability of experimental drugs for patients. Not only have 38 states already passed similar legislation, but the FDA already has a program in place designed to provide patients with experimental medications.

This program, known as the “compassionate use” program, performs essentially the same function as the right to try legislation, allowing patients to try experimental drugs after approval from a review board and panel of experts. In recent years, the FDA has approved 5,816 of 5,849 requests – a 99.4 percent approval rate.

While right to try would eliminate the FDA’s role in this process, the legislation does little more than slightly simplify a process that already exists to ensure that those who need experimental medications have access to them.

More Harm Than Good?

Ultimately, we believe right to try is poised to give the Trump administration a political win on a popular public policy but will do little to change the status quo for terminally ill patients. Some opponents say, if anything, it could give terminally ill patients false hope for new access to drugs they already can obtain through existing FDA policy.

Even if right to try does simplify federal regulation, patients must still convince a reticent pharmaceutical industry to provide drugs outside of trials, and patients must still bear the costs for these experimental treatments, which is out of reach for almost all Americans.

The right to try legislation will score the president and members on both sides of the aisle in Congress points, but ultimately it will change little for terminally ill patients and their families.

Morten Wendelbo is a development researcher specializing in complex emergency preparedness and response. He has experience working with inter-governmental institutions, as well as country and local governments to implement comprehensive response strategies to natural disasters.

Dr. Timothy Callaghan studies health policy and management, with expertise in health policy and politics, Medicaid, Medicaid expansion, health insurance and the Affordable Care Act.

This article was republished from The Conversation.

See also:
Slow Medicine: A Conversation With J. Ladd Bauer MD
CVS Merger With Aetna: Health Care Cure Or Curse?

The Conversation

Edit Module
Edit ModuleShow Tags
Edit Module Edit ModuleShow Tags

Daily Astrology

December 13, 2019

A fascinating early morning dream can be a potent motivator. If destiny or a newly discovered sense of purpose appeals to you, go for it! Venus’ late morning conjunction with Pluto signals profits for some investors. Other souls encounter big dramas in…
Edit ModuleShow Tags

Alternative Health Directory

Browse all listings »

Edit ModuleShow Tags
Edit ModuleShow Tags

Calendar

December 2019

Come shine with us! Join us in harmony and in our goal to bring the light of Spiritualism forward to all those who are searching.

Where:
VFW Post 2597
775 Boston Rd, Rt 3A
Billerica, MA
View map »


Sponsor: The Spiritualist Fellowship Church Of New England
Website »

More information

A beautiful collection of messages from Jeshua Ben Joseph (Jesus) that will transform your life, as it did his. Coming together to study these teachings, to ponder, to savor, to deepen our...

Cost: $25 per class

Where:
Heart and Soul Holistic Healing Center
130 Massapoag Avenue
Sharon, MA  02067
View map »


Sponsor: Heart and Soul Holistic
Telephone: 781-258-9942
Contact Name: Barbara Ann Strassman
Website »

More information

Show More...
Show Less...

2nd and 4th Monday of every month This psychic message circle is for anyone wishing to raise their connection using their psychic centers known as the “clairs.” Learn how to use...

Cost: $20

Where:
Messages From Heaven Healing and Learning Center
646 Central Street
Suite 3
Leominster, MA
View map »


Website »

More information

Show More...
Show Less...

Show More...
Show Less...

What is a vigorous yoga practice, and who can benefit from it? With Marissa McAleer and Julie Rost This workshop will explore a more physical practice of yoga and how it can be used to...

Cost: $45

Where:
YogaLife Institute of NH
6 Chestnut Street
Lower Level
Exeter, NH  03833
View map »


Sponsor: YogaLife Institute of NH
Contact Name: Alice Bentley
Website »

More information

The Wellness Roundtable Holistic Practitioners Network creates an environment for wellness practitioners to inspire, educate and support one another, while building community and encouraging...

Cost: $20 (Drop-ins are welcome)

Where:
Sohum Yoga and Meditation Studio
30 Lyman St
#108B
Westborough, MA
View map »


Sponsor: 01581
Telephone: 508-329-3338
Contact Name: Ritu Kapur
Website »

More information

How would it feel to have direct education on changing your feelings so you do start to ask for what you truly want? Each month, come and practice hands-on skills to get into the habit of...

Cost: $15

Where:
Awaken Holistic Counseling Services
2 Liberty St., Unit 2L
Newburyport, MA  01950
View map »


Sponsor: Awaken Holistic Counseling Services, LLC
Telephone: 978-255-7893
Contact Name: Kerri Morrison
Website »

More information

Show More...
Show Less...

The nights of December fall dark and early. Homes are filled with warm firelight and flickering candle glow. As the year draws to a close, pause under the peaceful light of December’s Full...

Cost: $10–15 suggested donation

Where:
A Touch of Magick
195 S Main Street
Uxbridge, MA
View map »


Telephone: (508) 779-7386
Website »

More information

Sound baths provide an opportunity to relax and journey into a healing, meditative and rejuvenating state. There is nothing you need to do, know or believe. Join us for a powerful, yet casual...

Cost: $25

Where:
Moth & Moon Studio
173 South River Rd
Suite #4
Bedford, NH  03110
View map »


Sponsor: Jeffrey Charles Warren
Contact Name: Jeffrey Warren
Website »

More information

Show More...
Show Less...

Multi-skilled, and varied holistic practitioner group in Lincoln Area / Metro-West Boston welcomes new practitioner-members. Open invitation to any local practitioner, teacher, researcher,...

Cost: Free, or $5-$15

Where:
Member-homes/offices
Lincoln, MA  01773-4107


Sponsor: Lincoln Area Wellness Collaborative
Telephone: 781-738-1920
Contact Name: Jai Kaur

More information

Show More...
Show Less...

This is a class that will teach you how to make your own wire-wrapped gemstone pendant! Don’t be discouraged—it is simpler than you think, and you’ll have great fun in crafting...

Cost: $40 per person or $35 more than one, includes supplies

Where:
The Healing Power of Flowers — Heaven and Earth
68 Stiles Rd, Unit A
Salem, NH  03079
View map »


Sponsor: The Healing Power of Flowers - Heaven and Earth
Telephone: 603-275-7688
Contact Name: Stacey
Website »

More information

Learn to overcome spinal tensions through therapeutic postures, designed to decompress your spine and relieve pain. Taught by a certified yoga therapist, classes bring you through poses...

Cost: 5/$50

Where:
Bliss Through Yoga
484 Bedford St
East Bridgewater, MA  02333
View map »


Telephone: 508-331-3564
Contact Name: Janice O'Brien
Website »

More information

Show More...
Show Less...
Edit ModuleShow Tags
Edit Module Edit ModuleShow Tags